Pivotal bioVenture Partners Fund I L.P. 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 9:41 pm Unchanged | 2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.100% | 0 (Unchanged) | Filing |
| 2021-08-13 5:02 pm Purchase | 2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.400% | 1,166,952 (+61.70%) | Filing |
| 2021-02-17 4:56 pm Purchase | 2021-02-09 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I L.P. | 1,891,467 5.500% | 1,891,467 (New Position) | Filing |